Breaking News Instant updates and real-time market news.

AERI

Aerie Pharmaceuticals

$55.35

2.65 (5.03%)

09:38
10/11/17
10/11
09:38
10/11/17
09:38

Aerie jumps after FDA posts briefing documents ahead of Rhopressa meeting

The FDA has called a meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee, to be held October 13, to discuss Aerie Pharmaceuticals' Rhopressa for the proposed indication of reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. As is its standard practice, the FDA has made background material available to the public two business days before the meeting. Following the posting of the briefing documents to the FDA website, Aerie shares are up 14% to $63.20 in early trading.

  • 13

    Oct

  • 28

    Feb

AERI Aerie Pharmaceuticals
$55.35

2.65 (5.03%)

09/07/17
MZHO
09/07/17
INITIATION
Target $70
MZHO
Buy
Aerie Pharmaceuticals initiated with a Buy on glaucoma opportunity at Mizuho
As previously reported, Mizuho initiated Aeri Pharmaceuticals with a Buy and a $70 price target. Analyst Difei.Yang said Aeri is well positioned for FDA approvals of its two glaucoma drugs, Rhopressa and Roclatan in 2018-2019. If both are approved, he said the drugs would bring options for treating glaucoma with the first new mechanism of actions in nearly 20 years and sees potential for a buyout ahead of the FDA approvals in 2018
09/22/17
JMPS
09/22/17
NO CHANGE
Target $68
JMPS
Outperform
Aerie pullback on AdComm announcement a buying opportunity, says JMP Securities
JMP Securities analyst Donald Ellis said Aerie management has broadcast their expectations for an advisory committee for Rhopressa "since day one" and he is still highly confident the vote will support a recommendation for approval. He views the pullback of the stock on the announcement of the meeting as a buying opportunity and reiterates his Outperform rating and $68 target on Aerie shares.
10/02/17
MZHO
10/02/17
NO CHANGE
Target $70
MZHO
Buy
Aerie recent weakness a buying opportunity, says Mizuho
Mizuho analyst Difei Yang noted that Aerie Pharmaceuticals shares have fallen by about 20% since the company announced on September 20 that the FDA will hold an advisory committee meeting to discuss Rhopressa. However, after speaking with Aerie's management, the analyst believes a fair amount of preparation had already taken place prior to receiving the FDA notice and views the pullback in the stock as a buying opportunity. Yang keeps a $70 price target and Buy rating on Aerie shares.
10/05/17
COWN
10/05/17
NO CHANGE
Target $100
COWN
Outperform
Aerie Pharmaceuticals should receive positive FDA review next week, says Cowen
Cowen analyst Tyler Van Buren conducted an ophthalmology panel and survey and received very optimistic responses suggesting Rhopressa should receive a positive advisory committee vote on October 13, which should ultimately lead to approval. The panelists he spoke to believed the company's Rocket clinical trial program demonstrated that Rhopressa is an effective agent as it achieved non-inferiority to timolol, said Van Buren, who reiterated his Outperform rating and $100 price target on Aerie Pharmaceuticals shares.

TODAY'S FREE FLY STORIES

C

Citi

$77.13

0.67 (0.88%)

10:20
02/21/18
02/21
10:20
02/21/18
10:20
Options
Sizable option prints in Citi as shares rally Wednesday »

Sizable option prints in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 06

    Mar

  • 07

    Mar

  • 30

    May

DLR

Digital Realty

$97.72

-1.865 (-1.87%)

10:20
02/21/18
02/21
10:20
02/21/18
10:20
Periodicals
Supreme Court throws out lawsuit against Digital Realty Trust »

Company whistleblowers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 05

    Mar

  • 27

    Mar

  • 03

    Apr

WD

Walker & Dunlop

$50.29

0.13 (0.26%)

10:20
02/21/18
02/21
10:20
02/21/18
10:20
Conference/Events
Walker & Dunlop management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

10:20
02/21/18
02/21
10:20
02/21/18
10:20
General news
Fed's Kashkari said "Wall Street reacts to everything," »

Fed's Kashkari said…

$NSD

NASDAQ Market Internals

10:17
02/21/18
02/21
10:17
02/21/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

10:16
02/21/18
02/21
10:16
02/21/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OMER

Omeros

$11.37

0.36 (3.27%)

10:14
02/21/18
02/21
10:14
02/21/18
10:14
Periodicals
Symphony data show Omidria sales fell 87% in January, Four World says »

Short seller Four World…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COLL

Collegium Pharmaceutical

$25.70

-0.2 (-0.77%)

10:12
02/21/18
02/21
10:12
02/21/18
10:12
Hot Stocks
FDA says Collegium made false or misleading claims about Xtampza »

The FDA posted a letter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 01

    Mar

VECO

Veeco

$18.35

-0.55 (-2.91%)

10:11
02/21/18
02/21
10:11
02/21/18
10:11
Conference/Events
Veeco management to meet with KeyBanc »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

CLF

Cleveland-Cliffs

$7.62

-0.12 (-1.55%)

10:10
02/21/18
02/21
10:10
02/21/18
10:10
Options
Bearish option flow in Cleveland Cliffs »

Bearish option flow in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:10
02/21/18
02/21
10:10
02/21/18
10:10
General news
U.S. existing home sales preview: »

U.S. existing home sales…

MTCH

Match Group

$42.10

0.54 (1.30%)

, IAC

IAC

$149.83

0.74 (0.50%)

10:09
02/21/18
02/21
10:09
02/21/18
10:09
Hot Stocks
Match Group slips after analyst cuts rating on Tinder slowdown »

Shares of Match Group…

MTCH

Match Group

$42.10

0.54 (1.30%)

IAC

IAC

$149.83

0.74 (0.50%)

ANGI

Angi Homeservices

$14.60

0.58 (4.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

MOS

Mosaic

$27.78

1.0176 (3.80%)

10:05
02/21/18
02/21
10:05
02/21/18
10:05
Options
Mosaic call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 28

    Feb

10:05
02/21/18
02/21
10:05
02/21/18
10:05
General news
More from Harker: a trade war would not be good »

More from Harker: a trade…

ABBV

AbbVie

$120.00

2.02 (1.71%)

10:05
02/21/18
02/21
10:05
02/21/18
10:05
Recommendations
AbbVie analyst commentary  »

Piper says 'hard to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

10:04
02/21/18
02/21
10:04
02/21/18
10:04
General news
Existing Home Sales data reported »

January Existing Home…

RDWR

Radware

$21.09

-0.25 (-1.17%)

10:04
02/21/18
02/21
10:04
02/21/18
10:04
Conference/Events
Radware management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 29

    Mar

RDWR

Radware

$21.09

-0.25 (-1.17%)

10:01
02/21/18
02/21
10:01
02/21/18
10:01
Conference/Events
Radware management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 29

    Mar

QTWO

Q2 Holdings

$42.85

-1.8 (-4.03%)

10:00
02/21/18
02/21
10:00
02/21/18
10:00
Conference/Events
Q2 Holdings management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 15

    Mar

10:00
02/21/18
02/21
10:00
02/21/18
10:00
General news
U.S. Markit manufacturing PMI rose 0.4 points to 55.9 in the flash February »

U.S. Markit manufacturing…

LFUS

Littelfuse

$208.66

0.61 (0.29%)

09:59
02/21/18
02/21
09:59
02/21/18
09:59
Conference/Events
Littelfuse management to meet with Oppenheimer »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

NJDCY

Nidec

$37.80

-0.12 (-0.32%)

09:57
02/21/18
02/21
09:57
02/21/18
09:57
Conference/Events
Nidec management to meet with Oppenheimer »

Group luncheon to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

HDP

Hortonworks

$18.22

0.03 (0.16%)

09:55
02/21/18
02/21
09:55
02/21/18
09:55
Conference/Events
Hortonworks management to meet with Northland »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

  • 26

    Feb

  • 11

    Mar

  • 13

    Mar

  • 14

    Mar

  • 11

    Apr

  • 30

    May

PVG

Pretium Resources

$6.56

-0.05 (-0.76%)

09:55
02/21/18
02/21
09:55
02/21/18
09:55
Options
Pretium Resources put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Mar

  • 11

    Mar

AAP

Advance Auto Parts

$115.88

10.53 (10.00%)

, EXR

Extra Space Storage

$84.86

4.105 (5.08%)

09:55
02/21/18
02/21
09:55
02/21/18
09:55
Options
Early notable gainers among liquid option names on February 21st »

Notable gainers among…

AAP

Advance Auto Parts

$115.88

10.53 (10.00%)

EXR

Extra Space Storage

$84.86

4.105 (5.08%)

MOS

Mosaic

$27.48

0.72 (2.69%)

CF

CF Industries

$42.80

0.975 (2.33%)

VRSK

Verisk Analytics

$97.04

-1.75 (-1.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 25

    Feb

  • 25

    Feb

  • 28

    Feb

  • 30

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.